Company
BelgiumGlaxoSmithKline Biologicals SA, Rixensart, Belgium – FDA Inspections
Inspection records and compliance data for GlaxoSmithKline Biologicals SA in Rixensart. 7 FDA inspections on record, 3 Form 483s, last inspected February 27, 2026.
Company Profile
This profile covers GlaxoSmithKline Biologicals SA based in Rixensart, Belgium.
FDA Inspection History
- FDA inspections
- 7
- OAI
- 0
- VAI
- 4
- NAI
- 1
- Unclassified
- 2
- Form 483s
- 3
- Warning letters
- 0
First inspected June 3, 2010. Last inspected February 27, 2026.
FDA inspections (7)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| February 27, 2026 | Not classified | Biologics | 1304664 |
| June 23, 2023 | NAI | Biologics · Vaccines and Allergenic Products | 1215345 |
| June 24, 2019 | Not classified | Biologics | 1099397 |
| January 27, 2017 | VAI | Biologics · Vaccines and Allergenic Products | 1007184 |
| October 2, 2014 | VAI | Biologics · Vaccines and Allergenic Products | 900625 |
| October 5, 2012 | VAI | Biologics · Vaccines and Allergenic Products | 818683 |
| June 3, 2010 | VAI | Biologics · Vaccines and Allergenic Products | 672159 |
FDA documents
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Corixa Corporation
Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.
AstraZeneca Pharmaceuticals LP
Merck Teknika LLC
Bio Products Laboratory Ltd
LifeSouth Community Blood Centers, Inc
Fresenius Kabi Horatev CZ s.r.o.
Octapharma AB
SmithKline Beecham Pharma GmbH & co. KG (dba GlaxoSmithKline Biologicals)
New York Blood Center Enterprises
Company Information
Name
GlaxoSmithKline Biologicals SA
FEI Number
3002875226
Address
Rue De L'Institut 89, Rixensart, Belgium
Country
Belgium
ID: ef569005-49c7-4bf9-b3f1-7814705bec8e